Sign Up to like & get
recommendations!
2
Published in 2023 at "JAMA Ophthalmology"
DOI: 10.1001/jamaophthalmol.2022.6254
Abstract: This post hoc analysis of the XIRIUS and XOLARIS studies investigates how changes in visual function associated with cotoretigene toliparvovec gene therapy in participants with RPGR-variant X-linked retinitis pigmentosa compare with those of untreated individuals.
read more here.
Keywords:
retinitis pigmentosa;
cotoretigene toliparvovec;
linked retinitis;
associated cotoretigene ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Advances in experimental medicine and biology"
DOI: 10.1007/978-3-319-95046-4_8
Abstract: X-linked retinitis pigmentosa (XLRP) is considered to be one of the most severe forms of retinitis pigmentosa (RP). It accounts for about 6-20% of all RP cases, including about 10% in the United States and…
read more here.
Keywords:
biology;
linked retinitis;
retinitis pigmentosa;
Sign Up to like & get
recommendations!
0
Published in 2022 at "Ophthalmic Genetics"
DOI: 10.1080/13816810.2022.2109686
Abstract: ABSTRACT Background X-linked retinitis pigmentosa (XLRP) is a rare inherited retinal disease predominantly affecting males. Materials and methods A comprehensive literature review was conducted to determine the prevalence of retinitis pigmentosa GTPase regulator (RPGR)-mutated XLRP.…
read more here.
Keywords:
prevalence;
linked retinitis;
retinitis pigmentosa;
rpgr mutated ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Acta Ophthalmologica"
DOI: 10.1111/aos.14662
Abstract: X‐linked retinitis pigmentosa (XLRP) accounts for a significant proportion of certifiable blindness in working‐age adults. The objectives of this study were to: (1) synthesize the best available evidence regarding the natural history of disease progression…
read more here.
Keywords:
systematic review;
linked retinitis;
retinitis pigmentosa;
natural history ... See more keywords